Shares of Surgery Partners Inc. (NASDAQ:SGRY) have been given an average recommendation of “Buy” by the eleven analysts that are covering the firm. One equities research analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation, six have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month target price among brokers that have issued ratings on the stock in the last year is $22.44.
Several brokerages have recently issued reports on SGRY. Zacks Investment Research downgraded shares of Surgery Partners from a “hold” rating to a “sell” rating in a research note on Wednesday. Barclays PLC initiated coverage on shares of Surgery Partners in a report on Wednesday, July 13th. They set an “equal weight” rating and a $20.00 price objective for the company. Finally, Jefferies Group reissued a “buy” rating and set a $27.00 price objective on shares of Surgery Partners in a report on Wednesday, August 10th.
In other Surgery Partners news, VP Jennifer Baldock sold 2,500 shares of the company’s stock in a transaction dated Monday, August 29th. The shares were sold at an average price of $19.20, for a total value of $48,000.00. Following the transaction, the vice president now owns 66,983 shares of the company’s stock, valued at $1,286,073.60. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 7.10% of the stock is currently owned by company insiders.
A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Acrospire Investment Management LLC boosted its position in Surgery Partners by 914.3% in the second quarter. Acrospire Investment Management LLC now owns 7,100 shares of the company’s stock worth $127,000 after buying an additional 6,400 shares during the last quarter. Royal Bank of Canada boosted its position in Surgery Partners by 3.9% in the first quarter. Royal Bank of Canada now owns 9,634 shares of the company’s stock worth $129,000 after buying an additional 366 shares during the last quarter. Bellevue Group AG bought a new position in Surgery Partners during the first quarter worth approximately $133,000. Parametric Portfolio Associates LLC bought a new position in Surgery Partners during the second quarter worth approximately $181,000. Finally, American International Group Inc. boosted its position in Surgery Partners by 19.7% in the second quarter. American International Group Inc. now owns 10,716 shares of the company’s stock worth $192,000 after buying an additional 1,766 shares during the last quarter. 38.32% of the stock is currently owned by institutional investors.
Surgery Partners (NASDAQ:SGRY) opened at 20.39 on Tuesday. The firm has a 50-day moving average of $19.44 and a 200 day moving average of $16.76. The company has a market capitalization of $989.53 million and a P/E ratio of 110.22. Surgery Partners has a one year low of $11.76 and a one year high of $22.32.
Surgery Partners (NASDAQ:SGRY) last issued its earnings results on Tuesday, August 9th. The company reported $0.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.14 by $0.02. The firm had revenue of $289.70 million for the quarter, compared to the consensus estimate of $275.99 million. Surgery Partners had a net margin of 2.63% and a return on equity of 18.80%. The business’s quarterly revenue was up 24.4% on a year-over-year basis. On average, equities analysts forecast that Surgery Partners will post $0.63 EPS for the current fiscal year.
Surgery Partners Company Profile
Surgery Partners, Inc is a healthcare services company. The Company operates in three lines of business across the United States: Surgical Facility Services, Ancillary Services and Optical Services. The Company’s Surgical Facility Services segment consists of the operation of ambulatory surgery centers (ASCs) and surgical hospitals, which include its anesthesia services.
Receive News & Ratings for Surgery Partners Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners Inc. and related companies with MarketBeat.com's FREE daily email newsletter.